Advertisement

Management of the Neck in Oral Cavity Cancer

  • Robert A. OrdEmail author
  • J. Lubek
Chapter

Abstract

Oral cancer is unusual in the Western countries, with an estimated 27,450 new cases for 2013 in the USA [1]. There has been a significant increase in 5-year relative survival rate between 1975–1978 and 2002–2008 of 53 % vs 65 % for all races, 54 % vs 67 % for whites, and 36 % vs 45 % for blacks. All of these were statistically significant (p < .05), although survival is still worse in blacks than whites [1]. This data is not true on global scale, and in many countries such as the Indian subcontinent, oral cavity cancer is more commonly seen due to habits such as the chewing of Betel Nut.

Keywords

Oral Cancer Neck Dissection Internal Jugular Vein Radical Neck Dissection Accessory Nerve 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Siegel R, Naishadham D, Jemal A. Cancer statistics 2013. CA Cancer J Clin. 2013;63:11–30.CrossRefPubMedGoogle Scholar
  2. 2.
    Shah JP, Candela FC, Poddar AK. The patterns of cervical metastases from squamous cell carcinoma of the oral cavity. Cancer. 1990;66:109–11.CrossRefPubMedGoogle Scholar
  3. 3.
    Shah JP, Andersen PE. The impact of nodal metastasis on modifications of neck dissection. Ann Surg Oncol. 1994;1(6):521–32.CrossRefPubMedGoogle Scholar
  4. 4.
    Li XM, Wei WI, Guo XF, Yeun PW, Lam LK. Cervical lymph node metastatic patterns of squamous cell carcinomas in the upper aerodigestive tract. J Laryngol Otol. 1996;110(10):937–41.CrossRefPubMedGoogle Scholar
  5. 5.
    Spiro JD, Spiro RH, Shah JP, Sessions RB, Strong EW. Critical assessment of supraomohyoid neck dissection. Am J Surg. 1988;156(4):286–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC cancer staging manual. 7th ed. New York/Dordrecht/Heidleberg/London: Springer; 2010.Google Scholar
  7. 7.
    Shah JP, Tollefson HR. Epidermoid carcinoma of the supraglottic larynx, role of neck dissection in initial surgical treatment. Am J Surg. 1974;128:494–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Ord RA. Current concepts in managing the neck in squamous cell carcinoma of the oral cavity. Oral Maxillofac Clin N Am. 1997;9(23):385–96.Google Scholar
  9. 9.
    Lyddiatt DD, Markin RS, Williams SM, Davis LF, Yonkers AJ. Computed tomography and magnetic resonance of cervical metastases of squamous cell carcinoma HeusschPHEof the upper respiratory and digestive tract. Otolaryngol Head Neck Surg. 1989;101:422–5.Google Scholar
  10. 10.
    Stern WB, Silver CE, Zeifer BA, Persky MS, Heller KS. Computed tomography of the clinically negative neck. Head Neck. 1990;12(2):109–13.CrossRefPubMedGoogle Scholar
  11. 11.
    Som PM. Lymph nodes of the head and neck. Radiology. 1987;165(3):593–600.CrossRefPubMedGoogle Scholar
  12. 12.
    Erkan MR, Ol AT, Guney E. Ultrasonography in laryngeal cancers. J Laryngol Otol. 1993;17:293–7.Google Scholar
  13. 13.
    Menda Y, Graham MM. Update on 18F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers. Semin Nucl Med. 2005;35(4):214–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Schöder H, Carlson DL, Kraus DH, Stambuk HE, Gönen M, Erdi YE, Yeung HW, Huvos AG, Shah JP, Larson SM, Wong RJ. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nucl Med. 2006;47(5):755–62.PubMedGoogle Scholar
  15. 15.
    Ozer E, Naiboğlu B, Meacham R, Ryoo C, Ryoo C, Argawal A, Schuller DE. The value of PET/CT to assess clinically negative necks. Eur Arch Otorhinolaryngol. 2012;269(11):2411–4.CrossRefPubMedGoogle Scholar
  16. 16.
    Varoquax A, Rager O, Poncet A, Delattre BM, Rahib O, Becker CD, Dulqueroy N, Zaidi H, Becker M. Detection and quantification of focal uptake in head and neck tumors: (18)F-FDG PET/MR versus PET/CT. Eur J Nucl Med Mol Imaging. 2014;41(3):462–75.CrossRefGoogle Scholar
  17. 17.
    Norling R, Burton BM, Thirkildsen MH, Henricksen BM, von Buchwald C, Nielsen MB. Staging of cervical lymph nodes in oral squamous cell carcinoma: adding ultrasound in clinically lymph node negative neck may improve diagnostic work-up. PLoS One. 2014;20(3):e90360.CrossRefGoogle Scholar
  18. 18.
    Heusch P, Sproll C, Buchbender C, Rieser E, Teriung J, Antke C, Boeck I, Macht S, Scherer A, Antoch G, Heusner TA, Handschel J. Diagnostic accuracy of ultrasound, 18F-FDG –PET Ct and fused 18 F-FDG-PET-MR images with DWI for the detection of cervical lymph node metastases of HNSCC. Clin Oral Investig. 2014;18(3):969–78.CrossRefPubMedGoogle Scholar
  19. 19.
    Chaukar D, Dandekar M, Kane S, Arya S, Purandare N, Rangaraian V, Desmukh A, Pal P, Chaturvedi P, D’Cruz A. Relative value of ultrasound, computed tomography imaging in the clinically node-negative neck in oral cancer. Asia Pac J Clin Oncol. 2014. doi: 10.1111/ajco.12255 (Epub ahead of print).PubMedGoogle Scholar
  20. 20.
    Liao LJ, Lo WC, Hsu WI, Wang CT, Lai MS. Detection of cervical node metastasis in head and neck cancer patients with clinically N0 neck- a meta-analysis comparing different imaging modalities. BMC Cancer. 2012;12:236.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Norling R, Grau C, Nielsen MB, Homøe P, Sørenson JA, Lambersen K, Bundgaard T, Mäkitie A, Grénman R, Larenne J, Koivunen P, Virtaniemi J, Gudionsson A, Jeflund O, Abendstein H, Rikardsen O, Lybak S, Wennerberg J, Högmo A, Westborn A, Hammerlid E, Tylor W, Cederblad L, von Buchwald C. Radiological imaging of the neck for initial decision making in oral squamous cell carcinomas- a questionnaire survey in the Nordic countries. Acta Oncol. 2012;51(3):355–61.CrossRefPubMedGoogle Scholar
  22. 22.
    Furukawa M, Dillon JK, Futran ND, Anzai Y. The prevelance of lymph node metastases in clinically N0 necks with oral cavity squamous cell carcinoma: is CT good enough for nodal staging? Acta Radiol. 2014;55(5):570–8.CrossRefPubMedGoogle Scholar
  23. 23.
    Joo Y, Yoo IR, Cho KJ, Park JO, Nam IC, Kim MS. Extracapsular spread and FDG PET/CT correlation in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2013;42(2):158–63.CrossRefPubMedGoogle Scholar
  24. 24.
    Joo YH, Yoo LR, Cho KJ, Park JO, Nam IC, Kim MS. Standardized uptake value and resection value and resection margin involvement predict outcomes in pN0 head and neck cancer. Otolaryngol Head Neck Surg. 2013;149(5):721–6.CrossRefPubMedGoogle Scholar
  25. 25.
    Higgins KA, Hoang JK, Roach MC, Chino J, Yoo DS, Turkington TG, Brizel DM. Analysis of pre-treatment FDG-PET SUV parameters in head and neck cancer. SUV mean has superior diagnostic value. Int J Radiat Oncol Biol Phys. 2012;82(2):548–53.CrossRefPubMedGoogle Scholar
  26. 26.
    Choi KH, Yoo LR, Han EJ, Kim YS, Kim GW, Na SJ, Di S, Jung SL, Jung CK, Kim MS, Lee SY, Kim SH. Prognostic value of metabolic tumor volume measured by (18)F-FDG PET/CT in locally advanced head and neck squamous cell carcinomas treated by surgery. Nucl Med Mol Imaging. 2011;45(1):43–51.CrossRefPubMedGoogle Scholar
  27. 27.
    Deron P, Mertens K, Goethals I, Rottey S, Duprez F, De Neve W, Vermeersch H, Van de Wiele C. Metabolic tumor prognostic value in locally advanced squamous cell carcinoma of the head and neck. Nuklearmedizin. 2011;50(4):141–6.CrossRefPubMedGoogle Scholar
  28. 28.
    Lee JC, Kim JS, Lee JH, Nam SY, Choi SH, Lee SW, Kim SB, Kim SY. F-18 FDG-PET as a routine surveillance tool for the detection of recurrent head and neck squamous cell carcinoma. Oral Oncol. 2007;43(7):686–92.CrossRefPubMedGoogle Scholar
  29. 29.
    Kim SY, Kim JS, Yi JS, Lee JH, Choi SH, Nam SY, Choi KJ, Lee SW, Kim SB, Roh JL. Evaluation of 18F- FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma. Ann Surg Oncol. 2011;18(9):2579–84.CrossRefPubMedGoogle Scholar
  30. 30.
    Baatenberg de Jong RJ, Rohgen RJ, Verwoerd CD, van Overhagen H, Laméris JS, Knegt P. Ultrasound-guided fine needle aspiration biopsy of neck nodes. Arch Otolaryngol Head Neck Surg. 1991;117:402–4.CrossRefGoogle Scholar
  31. 31.
    Van de Brekel MW, Catelijns JA, Siel HV, Luth WJ, Valk J, van der Waal I, Snow GB. Occult metastatic neck disease detection with US and US-guided fine needle aspiration cytology. Radiology. 1991;180:457–61.CrossRefPubMedGoogle Scholar
  32. 32.
    Stoeckli SJ, Haerle SK, Strobel K, Haile SR, Hany TF, Schuknecht B. Initial staging of the neck in head and neck squamous cell carcinoma: a comparison of CT, PET/CT, and ultrasound-guided fine-needle aspiration cytology. Head Neck. 2012;34(4):469–76.CrossRefPubMedGoogle Scholar
  33. 33.
    Flezar MS, Kirbis IS, Popović KS, Strojan P. Radiosensitivity of squamous cell carcinoma metastases to the neck assessed by immunocytochemical profiling of fine-needle aspiration biopsy cell specimens: a pilot study. Radiother Oncol. 2009;93(3):575–80.CrossRefPubMedGoogle Scholar
  34. 34.
    Adoga AA, Silas OA, Nimkur TL. Open cervical lymph node biopsy for head and neck cancers: any benefit? Head Neck Oncol. 2009;1:9.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Parsons JT, Million RR, Cassisi NJ. The influence of excisional or incisional biopsy of metastatic neck nodes on the management of head and neck cancer. Int J Radiat Oncol Biol Phys. 1985;11:1447–54.CrossRefPubMedGoogle Scholar
  36. 36.
    Vandenbrouk C, Sancho-garnier H, Chassagne D, Saravane D, Cachin Y, Micheau C. Elective versus therapeutic neck dissection in epidermoid carcinoma of the oral cavity: results of a randomized clinical trial. Cancer. 1980;46(2):386–90.CrossRefGoogle Scholar
  37. 37.
    Fakih AR, Rao RS, Borges AM, Patel AR. Elective versus therapeutic neck dissection in early carcinoma of the oral tongue. Am J Surg. 1989;153(4):309–13.CrossRefGoogle Scholar
  38. 38.
    Kligerman J, Lima RA, Soares JR, Prado L, Dias FL, Freitas EQ, Olivatto LO. Supraomohyoid neck dissection in the treatment of T1/T2 squamous cell carcinoma of oral cavity. Am J Surg. 1994;168(5):391–4.CrossRefPubMedGoogle Scholar
  39. 39.
    Yeun APW, Ho CM, Chow TL, Tang LC, et al. Prospective randomized study of selective neck dissection versus observation for N0 neck of early tongue carcinoma. Head Neck. 2009;31(6):765–72.CrossRefGoogle Scholar
  40. 40.
    Hosal AS, Carrau RL, Johnson JT, Myers EN. Selective neck dissection in the management of the clinically node-negative neck. Laryngoscope. 2000;110(12):2037–40.CrossRefPubMedGoogle Scholar
  41. 41.
    Alvi A, Johnson JT. Extracapsular spread in the clinically negative neck (N0): implications and outcome. Otolaryngol Head Neck Surg. 1996;114(1):65–70.CrossRefPubMedGoogle Scholar
  42. 42.
    Anderson PE, Cambronero E, Shaha AR, Shah JP. The extent of neck disease after regional failure during observation of the neck. Am J Surg. 1996;172(6):689–91.CrossRefGoogle Scholar
  43. 43.
    Yeun APW, Wei WI, Wong YM, Tang KC. Elective neck dissection versus observation in the surgical treatment of early oral tongue carcinoma. Head Neck. 1997;19:583–8.CrossRefGoogle Scholar
  44. 44.
    Rhee D, Wenig BM, Smith RV. The significance of immunohistochemically demonstrated nodal micrometastases in patients with squamous cell carcinoma of the head and neck. Laryngoscope. 2002;112(11):1970–4.CrossRefPubMedGoogle Scholar
  45. 45.
    Nieuwenhuis EJ, Leemans CR, Kimmer JA, Denkers F, Snow GB, Brakenhokk RH. Assessment and clinical significance of micrometastases in lymph nodes of head and neck cancer patients detected by E48 (Ly-6D) quantitative reverse transcription- polymerase chain reaction. Lab Invest. 2003;83(8):1233–40.CrossRefPubMedGoogle Scholar
  46. 46.
    Spiro RH, Huvos AG, Wong GY, Spiro JD, Gnecco CA, Strong E. Predictive value of tumor thickness in squamous carcinoma confined to the tongue and floor of the mouth. Am J Surg. 1986;152:345–50.CrossRefPubMedGoogle Scholar
  47. 47.
    Mohit-Tabatabai MA, Sobel HJ, Rush BF, Mashburg A. Relation of thickness of floor of mouth stage I and II cancers to metastasis. Am J Surg. 1986;152(4):351–3.CrossRefPubMedGoogle Scholar
  48. 48.
    Weiss MH, Harrison LB, Isaacs R. Use of decision analysis in planning a management strategy for the stage No neck. Arch Otolaryngol Head Neck Surg. 1994;120:694–702.CrossRefGoogle Scholar
  49. 49.
    Kraus DH, Rosenberg DB, Davidson BJ, Shaha AR, Spiro RH, Strong EW, Schantz SP, Shah JP. Supraspinal accessory nerve lymph node metastases in supraomohyoid neck dissection. Am J Surg. 1996;172(6):646–9.CrossRefPubMedGoogle Scholar
  50. 50.
    Talmi YP, Hoffman HT, Horowitz Z, McCullough TM, Funk GF, Graham SM, Peleg M, Yahalom R, Teicher S, Kroneberg J. Patterns of metastases to the upper jugular lymph nodes (the “submuscular recess”). Head Neck. 1998;20(8):682–6.CrossRefPubMedGoogle Scholar
  51. 51.
    Byers RM, Weber RS, Andrews T, Mc Gill D, Kare R, Wolf P. Frequency and therapeutic implications of “skip metastases” in the neck from squamous carcinoma of the oral tongue. Head Neck. 1997;19(1):14–9.CrossRefPubMedGoogle Scholar
  52. 52.
    Khafif A, Lopez-Garza JR, Medina JE. Is dissection of level IV necessary in patients with T1-3 N0 tongue cancer? Laryngoscope. 2001;111(6):1088–90.CrossRefPubMedGoogle Scholar
  53. 53.
    Leemans CR, Tiwari R, Naula JJ, Snow GB. Discontinuity vs in-continuity neck dissection in carcinoma of the oral cavity. Arch Otolaryngol Head Neck Surg. 1991;117(9):1003–6.CrossRefPubMedGoogle Scholar
  54. 54.
    Tesseroli MA, Calabrese L, Carvalho AL, Kowalski LP, Chiesa F. Discontinuous vs in-continuity dissection in carcinoma of the oral cavity. Experience of two oncologic hospitals. Arch Otolaryngol. 2006;26(6):350–5.Google Scholar
  55. 55.
    Zhang T, Ord RA, Wei WI, Zhao J. Sublingual lymph node metastases of early tongue cancer: report of two cases and review of the literature. Int J Oral Maxillofac Surg. 2011;40(6):597–600.CrossRefPubMedGoogle Scholar
  56. 56.
    Million RR. Is survival affected by elective irradiation of clinically uninvolved (N0) neck lymph nodes. [letter]. Int J Radiat Oncol Biol Phys. 1986;12:437–9.CrossRefGoogle Scholar
  57. 57.
    August M, Gianette K. Elective neck irradiation versus observation of the clinically negative neck of patients with oral cancer. J Oral Maxillofac Surg. 1996;54:1050–5.CrossRefPubMedGoogle Scholar
  58. 58.
    Fletcher GH. Elective irradiation of subclinical disease in cancers of the head and neck. Cancer. 1972;29:1450–4.CrossRefPubMedGoogle Scholar
  59. 59.
    Medina JE, Byers RM. Supra-omohyoid neck dissection: rationale, indications and surgical technique. Head Neck. 1989;11:111–22.CrossRefPubMedGoogle Scholar
  60. 60.
    Ord RA, Cornella FA. Modified radical and selective neck dissections. Atlas Oral Maxillofac Surg Clin North Am. 1997;5(2):111–32.PubMedGoogle Scholar
  61. 61.
  62. 62.
    Cooper JS, Palak TS, Forasttiere AA, et al.; Radiation Therapy Oncology Group 9501/Intergroup. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004;350(19):1937–44.Google Scholar
  63. 63.
    Bernier J, Domenge C, Ozsahin M, et al.; European Organization for Research and Treatment of Cancer Trial 22931. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350(19):1945–52.Google Scholar
  64. 64.
    Bernier J, Pfister DG, Cooper JS. Adjuvant chemo- and radiotherapy for poor prognosis head and neck squamous cell carcinoma. Crit Rev Oncol Hematol. 2005;56(3):353–64.CrossRefPubMedGoogle Scholar
  65. 65.
    Bernier J, Cooper JS, Palak TF, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501). Head Neck. 2005;27(10):843–50.CrossRefPubMedGoogle Scholar
  66. 66.
    Bernier J, Vermorken JB, Koch WM. Adjuvant therapy in patients with resected poor-risk head and neck cancer. J Clin Oncol. 2006;24(17):2629–35.CrossRefPubMedGoogle Scholar
  67. 67.
    Crile G. Excision of cancer of the head and neck with special reference to the plan of dissection based upon one hundred and thirty-two operations. JAMA. 1906;47:1780–6.CrossRefGoogle Scholar
  68. 68.
    Lingeman RE, Helmus C, Stephens R, Ulm J. Neck dissection: radical or conservative. Ann Otol Rhinol Laryngol. 1977;86:737–44.CrossRefPubMedGoogle Scholar
  69. 69.
    Bocca E, Pignataro O. A conservative technique in radical neck dissection. Ann Otol Rhinol Laryngol. 1967;76:975–88.CrossRefPubMedGoogle Scholar
  70. 70.
    Calaero CV, Teatini G. Functional neck dissection; anatomical grounds, surgical technique, clinical observations. Ann Otol Rhinol Laryngol. 1983;92:21–2.Google Scholar
  71. 71.
    Anderson PE, Shah JP. The role of comprehensive neck dissection with preservation of the spinal accessory nerve in the clinically positive neck. Am J Surg. 1994;168:499–503.CrossRefGoogle Scholar
  72. 72.
    Byers RM. Modified neck dissection: a study of 967 cases from 1970 to 1980. Am J Surg. 1985;150:414–21.CrossRefPubMedGoogle Scholar
  73. 73.
    O’Brien CJ, Lahr CJ, Soong SJ. Surgical treatment of early stage carcinoma of the oral tongue: would adjuvant treatment be beneficial? Head Neck Surg. 1986;8:401–8.CrossRefPubMedGoogle Scholar
  74. 74.
    Shah JP, Andersen PE. Evolving role of modifications in neck dissection for oral squamous carcinoma. Br J Oral Maxillofac Surg. 1995;33:3–8.CrossRefPubMedGoogle Scholar
  75. 75.
    Pantvaidya GH, Pal P, Vaidya AD, Pai PS, D’Cruz AK. Prospective study of 583 neck dissections in oral cancers: implications for clinical practice. Head Neck. 2014;36(10):1503–7.PubMedGoogle Scholar
  76. 76.
    Pellitteri PK, Robbins KT, Neuman T. Expanded application of selective neck dissection with regard to nodal status. Head Neck. 1997;19(4):260–5.CrossRefPubMedGoogle Scholar
  77. 77.
    Kolli VR, Data RV, Omer JB, Hicks Jr WL, Loree TR. The role of supraomohyoid neck dissection in patients with positive nodes. Arch Otolaryngol Head Neck Surg. 2000;126(3):413–6.CrossRefPubMedGoogle Scholar
  78. 78.
    Andersen PE, Warren F, Spiro J, Burningham A, Wong R, Wax MK, Shah JP, Cohen JI. Results of selective neck dissection in management of the node-positive neck. Arch Otolaryngol Head Neck Surg. 2002;128(10):1180–4.CrossRefPubMedGoogle Scholar
  79. 79.
    Ambrosch P, Kron M, Pradier O, Steiner W. The purpose of this study was to evaluate the efficacy of selective neck dissection (SND) in elective and therapeutic treatment of the neck. Otolaryngol Head Neck Surg. 2001;124(2):180–7.CrossRefPubMedGoogle Scholar
  80. 80.
    Patel RS, Clark JR, Gao K, O’Brien CJ. Effectiveness of selective neck dissection in the treatment of the clinically positive neck. Head Neck. 2008;30(9):1231–6.CrossRefPubMedGoogle Scholar
  81. 81.
    Givi B, Linkov G, Ganly I, Patel SG, Wong RJ, Singh B, Boyle JO, Shaha AR, Shah JP, Kraus DH. Selective neck dissection in node-positive squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg. 2012;147(4):707–15.CrossRefPubMedGoogle Scholar
  82. 82.
    Feng Z, Gao Y, Niu LX, Peng X, Guo CB. Selective versus comprehensive neck dissection in the treatment of patients with a pathologically node-positive neck with or without microscopic extracapsular spread in oral squamous cell carcinoma. J Oral Maxillofac Surg. 2014;43(10):1182–8.CrossRefGoogle Scholar
  83. 83.
    Parikh DG, Chheda YP, Shah SV, Patel AM, Sharma MR. Significance of level v lymph node dissection in clinically node positive oral cavity squamous cell carcinoma and evaluation of potential risk factors for level v lymph node metastasis. Indian J Surg Oncol. 2013;4(3):275–9.CrossRefPubMedPubMedCentralGoogle Scholar
  84. 84.
    Gallo O, Santoro R, Fiorini FR, Meccariello G, Laganà RM, Paiar F, Maio V. Prognostic role of internal jugular vein preservation in neck dissection for head and neck cancer. J Surg Oncol. 2013;108(8):579–83.CrossRefPubMedGoogle Scholar
  85. 85.
    Govers T, Patel S, Takes R, Merkx M, Rovers M, Grutters J. Cost-effectiveness of selective neck dissection versus modified radical neck dissection for treating metastases in oral cavity cancer patients; a modelling study. Head Neck. 2014. doi: 10.1002/hed.23833 [Epub ahead of print].Google Scholar
  86. 86.
    Feng Z, Niu LX, Yuan Y, Peng X, Guo CB. Risk factors and treatment of contralateral neck recurrence for unilateral oral squamous cell carcinoma: a retrospective study of 1482 cases. Oral Oncol. 2014;50(11):1081–8.CrossRefPubMedGoogle Scholar
  87. 87.
    Ord RA. Radical neck dissection. Atlas Oral Maxillofac Surg Clin North Am. 1997;5(2):91–110.PubMedGoogle Scholar
  88. 88.
    Kowalski LP. Results of salvage treatment of the neck in patients with oral cancer. Arch Otolaryngol Head Neck Surg. 2015;37(2):1762–8.Google Scholar
  89. 89.
    Wong LY, Wei WI, Lam LK, et al. Salvage of recurrent head and neck squamous cell carcinoma after primary curative surgery. Head Neck. 2003;25:953.CrossRefPubMedGoogle Scholar
  90. 90.
    Mabanta S, Mendenhall W, Stringer S, et al. Salvage treatment for neck recurrence after irradiation alone for head and neck squamous cell carcinoma with clinically positive neck nodes. Head Neck. 1999;21:591.CrossRefPubMedGoogle Scholar
  91. 91.
    Gleich LL, Ryzenman J, Gluckman J, et al. Recurrent advanced (T3 or T4) head and neck squamous cell carcinoma. Is salvage possible? Arch Otolaryngol Head Neck Surg. 2004;130:35.CrossRefPubMedGoogle Scholar
  92. 92.
    Ord RA, Kolokythas A, Reynolds MA. Surgical salvage for local and regional recurrence in oral cancer. J Oral Maxillofac Surg. 2006;64(9):1409–14.CrossRefPubMedGoogle Scholar
  93. 93.
    Amar A, Chedid HM, Rapoport A, Dedivitis RA, Cernea CR, Brandão LG, Curioni OA. Update of assessment of survival in head and neck cancer after regional recurrence. J Oncol. 2012;2012:154303. doi: 10.1155/2012/154303. Epub 2012 Oct 10.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  1. 1.Department of Oral and Maxillofacial SurgeryUniversity of Maryland and the Greenebaum Cancer CenterBaltimoreUSA
  2. 2.Oncology/Microvascular Program, Department of Oral and Maxillofacial SurgeryUniversity of Maryland and the Greenebaum Cancer CenterBaltimoreUSA

Personalised recommendations